Employees: 1-10
Portfolio 25
| Date | Name | Website | Total Raised | Location |
| 27.11.2023 | Apogee The... | apogeetherapeutics.com | $632M | United Sta... |
| 27.11.2023 | VYNE Thera... | vynetherapeutics.com | - | United Sta... |
| 15.08.2023 | DICE Thera... | dicetherapeutics.com | - | United Sta... |
| 15.03.2023 | Hemab Ther... | hemab.com | $347M | United Sta... |
| - | Upstream B... | upstreambio.com | $400M | United Sta... |
| - | Trefoil Th... | trefoiltherapeutics.com | $28M | United Sta... |
| - | Recludix P... | recludixpharma.com | - | United Sta... |
| - | Centessa P... | centessa.com | $250M | United Kin... |
| - | Eliem Ther... | eliemtx.com | $140M | United Sta... |
| - | Gamida Cel... | gamida-cell.com | $107.9M | United Sta... |
Show more
Mentions in press and media 1
| Date | Title | Description |
| 23.10.2023 | Which VCs are investing in rare diseases? | Firms include Chiesi Ventures, Frazier Healthcare Partners, OrbiMed, and Atlas Venture In the United States alone 25 million people suffer from rare disease, a number that jumps to 400 million people globally. While 1 in 10 people will suff... |